Jump to navigation Jump to search
Revision as of 18:18, 27 September 2011 by WikiBot (talk | contribs) (Protected "Promegapoietin": Protecting pages from unwanted edits ([edit=sysop] (indefinite) [move=sysop] (indefinite)))
Promegapoietin is a drug given during chemotherapy to increase blood cell regeneration. It is a colony-stimulating factor that stimulates megakaryocyte production.
It functions by stimulating ligands for interleukin 3 and c-Mpl.
- ↑ Kratz-Albers K, Scheding S, Möhle R, Bühring H, Baum C, Mc Kearn J, Büchner T, Kanz L, Brugger W (2000). "Effective ex vivo generation of megakaryocytic cells from mobilized peripheral blood CD34(+) cells with stem cell factor and promegapoietin". Exp Hematol. 28 (3): 335–46. PMID 10720698.
- ↑ http://www.cancer.gov/Templates/db_alpha.aspx?CdrID=46019
- ↑ Doshi P, Giri J, Abegg A, Favara J, Huynh M, Kahn L, Minnerly J, Pegg L, Villani-Price D, Siegel N, Staten N, Thomas J, McKearn J, Smith W (2001). "Promegapoietin, a family of chimeric growth factors, supports megakaryocyte development through activation of IL-3 and c-Mpl ligand signaling pathways". Exp Hematol. 29 (10): 1177–84. PMID 11602319.
- promegapoietin-1a at the US National Library of Medicine Medical Subject Headings (MeSH)